Christopher Bowden

2019

In 2019, Christopher Bowden earned a total compensation of $3.2M as Chief Medical Officer at Agios Pharmaceuticals, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$198,668
Option Awards$1,609,989
Salary$490,539
Stock Awards$915,590
Other$12,422
Total$3,227,208

Bowden received $1.6M in option awards, accounting for 50% of the total pay in 2019.

Bowden also received $198.7K in non-equity incentive plan, $490.5K in salary, $915.6K in stock awards and $12.4K in other compensation.

Rankings

In 2019, Christopher Bowden's compensation ranked 3,781st out of 13,971 executives tracked by ExecPay. In other words, Bowden earned more than 72.9% of executives.

ClassificationRankingPercentile
All
3,781
out of 13,971
73rd
Division
Manufacturing
1,369
out of 5,701
76th
Major group
Chemicals And Allied Products
478
out of 2,200
78th
Industry group
Drugs
402
out of 1,886
79th
Industry
Pharmaceutical Preparations
303
out of 1,398
78th

Pay ratio

Christopher Bowden's Pay$3,227,208
Median Employee's Pay$267,104
Pay Ratio

12

to 1

In 2019, the annual total compensation of Christopher Bowden was $3,227,208.

The annual total compensation of the median employee at Agios Pharmaceuticals was $267,104.

The ratio of Christopher Bowden's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 16, 2020.

Bowden's colleagues

We found five more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2019.

2019

Jacqualyn Fouse

Agios Pharmaceuticals

Chief Executive Officer

2019

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2019

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2019

Jonathan Biller

Agios Pharmaceuticals

Chief Legal Officer

2019

David Schenkein

Agios Pharmaceuticals

Chief Executive Officer

News

You may also like